Skip to content
Products & Services · Total revenues

Prolia — Total revenues

Amgen Prolia — Total revenues decreased by 91.6% to $727M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 91.1%, from $8.15B to $727M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026Apr 30, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market adoption, successful commercial execution, or expanded clinical usage, while a decrease may signal increased competition, patent expiration, or market saturation.

Detailed definition

This metric represents the total gross sales generated by a specific therapeutic product line within the company's portf...

Peer comparison

Similar to product-specific revenue reporting in other large-cap pharmaceutical and biotechnology companies, which track the performance of key blockbuster drugs.

Metric ID: amgn_segment_prolia_total_revenues

Historical Data

40 periods
 Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25Q4 '25Q4 '25Q1 '26Q1 '26
Value$6.53B$814M$6.71B$803M$6.85B$873M$6.24B$852M$6.59B$922M$6.65B$862M$6.84B$992M$6.11B$927M$6.99B$1.03B$6.9B$986M$8.2B$1.11B$7.45B$999M$8.39B$1.17B$8.5B$1.05B$9.09B$1.17B$8.15B$1.1B$9.18B$1.12B$9.56B$1.14B$9.87B$1.05B$8.62B$727M
QoQ Change-87.5%+723.8%-88.0%+752.6%-87.2%+614.5%-86.3%+673.9%-86.0%+621.5%-87.0%+693.4%-85.5%+515.4%-84.8%+653.6%-85.3%+571.5%-85.7%+731.2%-86.5%+572.7%-86.6%+739.6%-86.1%+629.9%-87.7%+769.5%-87.2%+599.5%-86.5%+735.2%-87.8%+751.8%-88.1%+766.2%-89.3%+717.6%-91.6%
YoY Change+1.0%-85.9%-0.8%-87.1%-0.1%-85.5%-2.1%-85.1%+5.9%-84.4%+3.8%-85.2%+19.8%-83.8%+22.0%-83.6%+20.1%-83.3%+23.2%-84.9%+10.9%-85.8%+9.4%-85.2%+9.4%-86.6%+12.4%-86.6%+8.6%-88.4%+5.8%-91.1%
Range$727M$9.87B
CAGR-20.2%
Avg YoY Growth-38.2%
Median YoY Growth-42.7%

Frequently Asked Questions

What is Amgen's prolia — total revenues?
Amgen (AMGN) reported prolia — total revenues of $727M in Q1 2026.
How has Amgen's prolia — total revenues changed year-over-year?
Amgen's prolia — total revenues decreased by 91.1% year-over-year, from $8.15B to $727M.
What does prolia — total revenues mean?
The total amount of money earned from sales of a specific drug product.